Market Tracker

11/24 8:33am ET

SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

8.63
Data as of Nov 21
 -0.05 / -0.58%
Today’s Change
4.24
Today|||52-Week Range
8.89
+71.23%
Year-to-Date

Today’s Trading

Previous close8.68
Today’s open8.77
Day’s range-- - --
Volume529,609
Average volume (3 months)643,996
Market cap$438.2M
Dividend yield--
Data as of 11/21/2014

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+180.00%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)-18.69%
P/E ratio21.0
Price/Sales2.13
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.02+0.14%
VTLVital Therapies Inc-0.59-3.09%
VSARVersartis Inc-0.49-2.66%
PETXAratana Therapeutics...+0.34+2.70%
Data as of 11/21/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)$0.15
Annual revenue (last year)$127.1M
Annual profit (last year)$11.0M
Net profit margin8.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts